M2 macrophage-derived exosomal miR-26b-5p regulates macrophage polarization and chondrocyte hypertrophy by targeting TLR3 and COL10A1 to alleviate osteoarthritis

Yufan Qian,Genglei Chu,Lei Zhang,Zhikai Wu,Qiuyuan Wang,Jiong Jiong Guo,Feng Zhou
DOI: https://doi.org/10.1186/s12951-024-02336-4
IF: 10.2
2024-02-20
Journal of Nanobiotechnology
Abstract:Osteoarthritis (OA) is one of the most prevalent chronic musculoskeletal diseases among the elderly population. In this study, macrophage-derived exosomes were isolated and identified. Exosomes were subjected to microRNA (miRNA) sequencing and bioinformatic analysis, and differentially expressed miRNAs were verified. miR-26b-5p target genes were confirmed through target-site mutation combined with a dual-luciferase reporter assay. The effects of miR-26b-5p on macrophage polarization and chondrocyte hypertrophy were assessed in vitro. miR-26b-5p agomir was applied to mice with OA induced by anterior cruciate ligament transection (ACLT). The therapeutic effects of miR-26b-5p were evaluated via pain behavior experiments and histological observations. In vitro, miR-26b-5p repolarized M1 macrophages to an anti-inflammatory M2 type by targeting the TLR3 signaling pathway. miR-26b-5p could target COL10A1, further inhibiting chondrocyte hypertrophy induced by M1 macrophage-conditioned medium (M1-CM). In vivo, miR-26b-5p agomir ameliorated gait abnormalities and mechanical allodynia in OA mice. miR-26b-5p treatment attenuated synovitis and cartilage degeneration, thereby delaying OA progression. In conclusion, M2 macrophage-derived exosomal miR-26b-5p could protect articular cartilage and ameliorate gait abnormalities in OA mice by targeting TLR3 and COL10A1. miR-26b-5p further affected macrophage polarization and chondrocyte hypertrophy. Thus, this exosomal miR-26b-5p-based strategy might be a potential method for OA treatment.
biotechnology & applied microbiology,nanoscience & nanotechnology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: by studying the mechanism of action of miR - 26b - 5p in exosomes derived from M2 macrophages in osteoarthritis (OA), to explore the possibility of its being a potential method for treating osteoarthritis. Specifically, the paper mainly focuses on the following points: 1. **The relationship between macrophage polarization and osteoarthritis**: The paper explores how miR - 26b - 5p in exosomes derived from M2 macrophages can re - polarize pro - inflammatory M1 macrophages into anti - inflammatory M2 macrophages by targeting the TLR3 signaling pathway, thereby reducing the inflammatory response. 2. **The relationship between chondrocyte hypertrophy and osteoarthritis**: The paper studies how miR - 26b - 5p can inhibit chondrocyte hypertrophy induced by M1 macrophage - conditioned medium (M1 - CM) by targeting COL10A1, and then protect articular cartilage. 3. **The potential of miR - 26b - 5p in the treatment of osteoarthritis**: The paper evaluates the effects of miR - 26b - 5p in improving gait abnormalities, reducing mechanical hyperalgesia, alleviating synovitis and cartilage degeneration in osteoarthritis mice through in - vivo experiments. In summary, this paper aims to provide a theoretical basis and experimental evidence for the development of new osteoarthritis treatment methods by in - depth study of the mechanism of action of miR - 26b - 5p in osteoarthritis.